Aflac Incorporated Q2 adjusted EPS misses estimates on weaker yen
Aflac Incorporated Q2 adjusted EPS misses estimates on weaker yen
Overview
U.S. supplemental insurer's Q2 revenue declined 1%, missing analyst expectations
Adjusted EPS for Q2 fell 1.7% to $1.75, missing analyst expectations
Company cited weaker yen and lower Japan earnings as factors in quarterly results
Outlook
Company did not provide specific financial guidance for the current or future periods in the press release
Result Drivers
WEAKER YEN - Co said weaker yen/dollar exchange rate reduced reported adjusted earnings per share by $0.05 in Q2
JAPAN SEGMENT - Co said lower Japan net earned premiums were mainly due to new external reinsurance transaction and limited pay products reaching paid-up status
HIGHER BENEFITS IN U.S. - Co said U.S. pretax adjusted earnings declined 4.6% in Q2, primarily driven by higher benefits
Company press release: ID:nPn6H9ZZMa
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q2 Revenue | Miss | $4.10 bln | $4.16 bln (6 Analysts) |
Q2 Adjusted EPS | Miss | $1.75 | $1.77 (14 Analysts) |
Q2 EPS |
| $1.63 |
|
Q2 Adjusted Net Income | Miss | $883 mln | $911.18 mln (8 Analysts) |
Q2 Net Income |
| $825 mln |
|
Analyst Coverage
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 3 "strong buy" or "buy", 10 "hold" and 3 "sell" or "strong sell"
The average consensus recommendation for the life & health insurance peer group is "hold"
Wall Street's median 12-month price target for Aflac Incorporated is $116.00, about 7.6% below its August 5 closing price of $125.56
The stock recently traded at 17 times the next 12-month earnings vs. a P/E of 15 three months ago
Reuters Recommended Reads
Aug 5 - MetLife Q2 adjusted profit beats estimates on favorable underwriting, broad-based volume growth
Aug 5 - Brighthouse Financial Q2 adjusted EPS misses estimates as investment income falls
Aug 5 - Primerica Q2 revenue rises on strong client demand, favorable equity markets
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)
Recent news on Aflac Incorporated
See all newsUS RESEARCH ROUNDUP-3M, C4 Therapeutics, PepsiCo
U.S. RESEARCH ROUNDUP-Accendra Health, Celestica, Sionna Therapeutics
Aflac Incorporated reports results for the quarter ended June 30 - Earnings Summary
Insurer Aflac misses quarterly profit estimates on stronger dollar
Aflac Incorporated Q2 adjusted EPS misses estimates on weaker yen